Home / Import refusals / BFV-0772299-4/11/1

FDA Import Refusal BFV-0772299-4/11/1 — Centrient Pharmaceuticals India Private Limited

Centrient Pharmaceuticals India Private Limited — FEI 3004497364

The FDA refused shipment BFV-0772299-4/11/1 from Centrient Pharmaceuticals India Private Limited (India) on November 23, 2022. The refused product falls under Drugs and Biologics — ROSUVASTATIN CALCIUM. Cited charges: 118,75 This firm has 2 other import refusals on record.

Refusal Details

Date
November 23, 2022
Country
India
Product Category
Drugs and Biologics
Product Code
61JCG16 ROSUVASTATIN CALCIUM
Charges
118,75

Recent inspections

  • 1310126 (OAI Tue Jan 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1175790 (OAI Fri Jul 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1050153 (OAI Fri Apr 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 954842 (VAI Fri Dec 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

Compliance actions

Other import refusals

  • BFV-0772299-4/21/1 (Wed Nov 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-8582977-4/1/1 (Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources